Medicago's New Drug Submission accepted for scientific review ...
QUEBEC CITY, Oct. 3, 2019 /PRNewswire-AsiaNet/ -- Medicago, a biotechnology company and global leader in the development and production of plant-derived vaccines with headquarters in Quebec City, announces today that Health Canada accepted for scientific review its New Drug Submission (NDS) for a...
Authors: LATEST ASIANET NEWS RELEASES